Predicting Clinical Dementia Rating Using Blood RNA Levels
Open Access
Abstract
The Clinical Dementia Rating (CDR) is commonly used to assess cognitive decline in Alzheimer’s disease patients and is included in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. We divided 741 ADNI participants with blood microarray data into three groups based on their most recent CDR assessment: cognitive normal (CDR = 0), mild cognitive impairment (CDR = 0.5), and probable Alzheimer’s disease (CDR ≥ 1.0). We then used machine learning to predict cognitive status using only blood RNA levels. Only one probe for chloride intracellular channel 1 (CLIC1) was significant after correction. However, by combining individually nonsignificant probes with p-values less than 0.1, we averaged 87.87% (s = 1.02) predictive accuracy for classifying the three groups, compared to a 55.46% baseline for this study due to unequal group sizes. The best model had an overall precision of 0.902, recall of 0.895, and a receiver operating characteristic (ROC) curve area of 0.904. Although we identified one significant probe in CLIC1, CLIC1 levels alone were not sufficient to predict dementia status and cannot be used alone in a clinical setting. Additional analyses combining individually suggestive, but nonsignificant, blood RNA levels were significantly predictive and may improve diagnostic accuracy for Alzheimer’s disease. Therefore, we propose that patient features that do not individually predict cognitive status might still contribute to overall cognitive decline through interactions that can be elucidated through machine learning.Keywords
All Related Versions
Funding Information
- National Institutes of Health (RF1 AG054052)
This publication has 28 references indexed in Scilit:
- Older Primary Care Patients’ Attitudes and Willingness to Screen for DementiaJournal of Aging Research, 2015
- p38α (MAPK14) critically regulates the immunological response and the production of specific cytokines and chemokines in astrocytesScientific Reports, 2014
- Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter HyperintensitiesAlzheimer Disease & Associated Disorders, 2014
- Cognitive memory screening and referral program in community pharmacies in the United StatesInternational Journal of Clinical Pharmacy, 2013
- Greater Precision when Measuring Dementia Severity: Establishing Item Parameters for the Clinical Dementia Rating ScaleDementia and Geriatric Cognitive Disorders, 2012
- Cognitive screening tests as experienced by older hospitalised patients: a qualitative studyScandinavian Journal of Caring Sciences, 2011
- CLIC1 Function Is Required for β-Amyloid-Induced Generation of Reactive Oxygen Species by MicrogliaJournal of Neuroscience, 2008
- Validity of the Clinical Dementia Rating Scale for the Detection and Staging of Dementia in Brazilian PatientsAlzheimer Disease & Associated Disorders, 2007
- Involvement of the Intracellular Ion Channel CLIC1 in Microglia-Mediated -Amyloid-Induced NeurotoxicityJournal of Neuroscience, 2004
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982